Pallas Capital Advisors LLC, a registered investment adviser, initiated a new position in Bruker Corporation (NASDAQ:BRKR) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 9,480,665 shares of the Healthcare company, valued at approximately $446,634,130 as of the filing date.
Bruker Corporation's stock currently trades at $49.73 with a market capitalization of $7,035,113,377.
